New Injectables For Knee OA Fuel US Joint Fluid Market
Executive Summary
Although several factors have recently slowed growth in the US market for joint fluid replacement, it remains large and vastly underpenetrated with an estimated 15.8 million knee osteoarthritis patients who are hoping to delay the need for a total knee arthroplasty. With a growing number of products in the pipeline and increasing adoption of new single-injection products, the US joint fluid market is projected to increase from approximately $924.4 million in 2015 to more than $1.07 billion by 2019, a CAGR of 4%.